итак по-русски вкратце. из "оффициальных источников" инфицирование хлам.трахомат. ведет к тазовым болям (острым и хроническим), бесплодию, эктопической беременности, эпидидимитам, стриктуре уретры, артритам (в том числе распр. в крови), заболеваниям глаз, пневмониям. инфец. хламидией пневмониае может привести к гипертоние, атеросклерозу, заболеванию коронарных артерий, инфаркту миокарда, болезни сонной артерии и церебрально-васкулярной болезни.
Washington State Dept. of Health
STD fact sheet
Major STDs in the United States ...
Chlamydia bacterium (Chlamydia trachomatis) Estimated Annual Incidence, 1994: 4,000,000
Major Long-Term Health Consequences Adults: Women: pelvic inflammatory disease, infertility, ectopic pregnancy, chronic (long term) pelvic pain.
----------------
American Academy of Family Physicians
G o o g l e's text-only cache of as retrieved on 7 Sep 2005 04:23:47 GMT
August 1999 - AFP
Reactive Arthritis (Reiter's Syndrome)
WERNER F. BARTH, M.D., and KINIM SEGAL, M.D.
Washington Hospital Center
Washington, D.C.
...The syndrome most frequently follows genitourinary infection with Chlamydia trachomatis, but other organisms have also been implicated. Treatment with doxycycline or its analogs sometimes shortens the course or aborts the onset of the arthritis. ... Multiple organisms can trigger Reiter's syndrome following a genitourinary infection or infectious enteritis.6 The clinical picture following any of these conditions is virtually identical. Chlamydia trachomatis infection is the most common antecedent of reactive arthritis and accounts for most cases of venereal origin. Reactive arthritis has occurred following a well-documented gonococcal infection, despite adequate treatment of the infection. This finding has led to the use of doxycycline (Vibramycin) or an analog as adjunctive therapy for gonococcal disease, to prevent simultaneous infection with Chlamydia.... When Chlamydia is the suspected causative agent, patients may be given doxycycline or an analog for up to three months, but the optimal duration of therapy is unknown. In one study,12 it was found that when lymecycline, a tetracycline analog, was given for three months, disease duration was shortened to 15 weeks in 50 percent of patients, compared with over 39 weeks' duration in the placebo group....
-----------------------------
National Inst.ofArthritis&Musculoskeletal&Skin Diseases
"What Causes Reactive Arthritis, commonly known as chlamydia (pronounced kla-MID-e-a). It is usually acquired through ЭТОСПАМual contact. Some evidence also shows that respiratory infections with Chlamydia pneumoniae may trigger reactive arthritis. Infections in the digestive tract that may trigger reactive arthritis include Salmonella, Shigella, Yersinia, and Campylobacter. People may become infected with these bacteria after eating or handling improperly prepared food, such as meats that are not stored at the proper temperature."
---------------------
Univ.of Minnesota
edu/hmed/1998/02/19980215_chlamy.html' target='_blank'>
Antibodies to [b]Chlamydia pneumoniae as compared to 17 percent in the control group. These findings support the germ theory of hypertension.
--------------
[b]ОБЗОРНАЯ СТАТЬЯ
]
[b]Chlamydia pneumoniae and Cardiovascular Disease Lee Ann Campbell, Cho-Chou Kuo, and J. Thomas Grayston
[b]University of Washington, Seattle, Washington, USA
...Chlamydia pneumoniae is a ubiquitous pathogen that causes acute respiratory disease. The spectrum of C. pneumoniae infection has been extended to atherosclerosis and its clinical manifestations. Seroepidemiologic studies have associated C. pneumoniae antibody with coronary artery disease, myocardial infarction, carotid artery disease, and cerebrovascular disease. The association of C. pneumoniae with atherosclerosis is corroborated by the presence of the organism in atherosclerotic lesions throughout the arterial tree and the near absence of the organism in healthy arterial tissue. C. pneumoniae has also been isolated from coronary and carotid atheromatous plaques. To determine whether chronic infection plays a role in initiation or progression of disease, intervention studies in humans have been initiated, and animal models of C. pneumoniae infection have been developed. This review summarizes the evidence for the association and potential role of C. pneumoniae in cardiovascular disease. ...